Feedback / Questions
Axpaxli (intravitreal axitinib implant) - Ocular Therapeutix
https://www.globenewswire.com/news-release/2026/02/13/3238349/0/en/Ocular-Therapeutix-to-Announce-Topline-Data-for-SOL-1-Phase-3-Superiority-Trial-in-Wet-AMD-on-Tuesday-February-17-2026.html
Feb 13, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next